APA (7th ed.) Citation

I. V. Kolyadina. (2021). 10 years of success achieved by eribulin while treating HER2-negative mBC: From randomized studies to routine practice. ABV-press.

Chicago Style (17th ed.) Citation

I. V. Kolyadina. 10 Years of Success Achieved by Eribulin While Treating HER2-negative MBC: From Randomized Studies to Routine Practice. ABV-press, 2021.

MLA (9th ed.) Citation

I. V. Kolyadina. 10 Years of Success Achieved by Eribulin While Treating HER2-negative MBC: From Randomized Studies to Routine Practice. ABV-press, 2021.